Johnson & Johnson (JNJ)

125.91
0.92 0.73
NYSE : Health Technology
Prev Close 126.83
Open 126.93
Day Low/High 125.41 / 127.46
52 Wk Low/High 122.15 / 148.32
Volume 4.28M
Avg Volume 7.95M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 339.78B
EPS 0.50
P/E Ratio 269.49
Div & Yield 3.36 (2.63%)

Latest News

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

The big story is about cloud adoption.

Dow Jumps Over 200 Points; S&P 500 and Nasdaq Also Finish Higher

Dow Jumps Over 200 Points; S&P 500 and Nasdaq Also Finish Higher

Stocks rise on Tuesday as investors react to strong earnings from Goldman Sachs and Netflix.

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss Netflix and the FANGS, stock picking rewarded, and a way to hide from political risk.

Goldman Sachs, Netflix, Tesla - 5 Things You Must Know Before the Market Opens

Goldman Sachs, Netflix, Tesla - 5 Things You Must Know Before the Market Opens

U.S. stock futures point to gains for Wall Street on Tuesday; Goldman Sachs, UnitedHealth and Johnson & Johnson report earnings; Netflix surges after it posts impressive subscriber growth; Tesla to temporarily suspend production of Model 3 sedan.

Wall Street Looks To Extends Gains After Goldman Earnings Beat, China Data

Wall Street Looks To Extends Gains After Goldman Earnings Beat, China Data

Global stocks bumped higher Tuesday, while Wall Street futures suggested another positive open, as investors digested a mix set of economic readings from China and continued to focus on the U.S. corporate earnings season.

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Syria, James Comey, Bank of America, WPP and Starbucks - 5 Things You Must Know

Syria, James Comey, Bank of America, WPP and Starbucks - 5 Things You Must Know

U.S. stock futures are rising Monday as concerns over prolonged military action in Syria fade; Bank of America and Netflix report earnings on Monday; Former FBI Director James Comey says Donald Trump 'morally unfit' to be president; WPP CEO Martin Sorrell quits.

Washington Woes Slam Stocks: Cramer's 'Mad Money' Recap (Friday 4/13/18)

Washington Woes Slam Stocks: Cramer's 'Mad Money' Recap (Friday 4/13/18)

President Trump is creating a level of uncertainty that breeds selling. But Jim Cramer has your game plan for next week.

Week in Review: Wall Street Cowers in Washington's Shadow, Leaving Markets Mixed

Week in Review: Wall Street Cowers in Washington's Shadow, Leaving Markets Mixed

Markets have been mixed throughout the week, again extra sensitive to the fragile trade relationship between the U.S. and China. Plus, earnings season gets going and Facebook faces the music.

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.

Buy This Dividend-Paying Titan Amid Market Decline

Buy This Dividend-Paying Titan Amid Market Decline

Cisco Systems yield 3.2%, has decent growth and a reasonable valuation. Plus, double-digit returns could be in store.

Why Apple Is Still the Best Stock to Own for Your Retirement

Why Apple Is Still the Best Stock to Own for Your Retirement

Apple gives investors everything they want: A low valuation, solid growth and a huge capital return plan.

Where (and How) to Find 'Dividend Aristocrats'

Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Finding Stocks Right For You: Cramer's 'Mad Money' Recap (Wednesday 4/4/18)

Finding Stocks Right For You: Cramer's 'Mad Money' Recap (Wednesday 4/4/18)

Jim Cramer says it's extremely important to buy stocks that are suitable for you and your level of risk tolerance.

Jim Cramer: Markets Seek Domestic Tranquility

Jim Cramer: Markets Seek Domestic Tranquility

Stock markets ran higher as investors turned towards domestic-focused companies.

Why Uber's Self-Driving Car Fatality Won't End Autonomous Driving

Why Uber's Self-Driving Car Fatality Won't End Autonomous Driving

The fatality that came at the hands of a self-driving Uber vehicle was tragic. But keep in mind, self-driving cars will be safer than human drivers in the not-too-distant future.

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

It's hard to watch the market fall. But knowing you're still getting paid while it happens can make it much more palpable. That's why you need to have some dividend-producing stocks in your portfolio. Watch our video to find out why!

Income Seeker: Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Stocks Finish Higher in Volatile Day of Trading

Stocks Finish Higher in Volatile Day of Trading

Stocks rise Tuesday, as the Dow Jones Industrial Average claws back some losses following a selloff in the previous session.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were able to close the day in the green after a volatile day of trading.

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact The Firm

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

Nike Loses Traction, GOOD Looks Bad, and 3 Other Big-Name Bearish Bets

NKE, C, GM, JNJ and GOOD were all recently downgraded by TheStreet's Quant Ratings service.

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Johnson & Johnson Investors (JNJ)

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Johnson & Johnson Investors (JNJ)

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of Johnson & Johnson ("J&J" or the...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATV, CLR, JCAP, MUX Downgrades: FDP, JNJ, RICK, SND, SO, ZIXI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Is General Electric Stock Still Good for Your Retirement Account?

Is General Electric Stock Still Good for Your Retirement Account?

General Electric stock is making new multi-year lows. Depending on the investor though, there are moves they can make to soften the blow.

TheStreet Quant Rating: C+ (Hold)